Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

NCT: NCT04187105 · RECRUITING

NCT IDNCT04187105
StatusRECRUITING
Start Date2020-01-27
Completion2026-12

Brief Summary

This study is being done to see if the addition of a targeted form of radiation to standard conditioning regimen will increase the amount of cancer cells that are killed off in the bone marrow and reduce the chances that your disease may return. This description is called Intensity Modulated Total Marrow Irradiation (IM-TMI).

Frequently Asked Questions

What is BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)?

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) is a clinical trial registered under NCT04187105. Current status: RECRUITING.

What is the status of NCT04187105?

The current status of NCT04187105 (BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)) is: RECRUITING.

When did BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) start?

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) started on 2020-01-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑